Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Walker: T and B cell Mechanisms of HIV control: Implications for Vaccine Design |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Characterization |
| Species: | Non-organism study |
| Stage: | Assays complete |
| Study Start Date: | 2017-08-09 |
| Study Made Public: | 2018-09-18 |
Title
Atreca nab screen
Description
CAVD 678 is a monoclonal antibody screening study.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.